GENOVIS AB SE-40
Research GENOVIS AB SE-40 (5GV) on Bullrun: market cap EUR 119.00M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker5GV
- ExchangeF
- CountrySweden
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 119.00M
- Financial periodQ2 2026
- RevenueSEK 34.32M
- Net incomeSEK 1.31M
- Free cash flowSEK 7.91M
- Gross margin90.2%
Valuation Snapshot
latest market cap is EUR 119.00M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | SEK 128.95M | SEK 23.50M | SEK 32.02M | 89.8% | 0.35 | SEK 163.19M | SEK 73.08M | SEK 271.52M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-27 | EUR 119.00M | n/a | n/a | n/a |
About GENOVIS AB SE-40
Genovis AB (publ.) develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia. The company provides FabRICATOR, FabALACTICA, FabRICATOR Z, GingisKHAN, FabULOUS (SpeB), a cysteine protease; FabDELLO, a protease that digests human IgG1; IgASAP, an IgA-digesting enzyme; and IgMBRAZOR, an IgM-specific protease. It also offers GlySERIAS, an enzyme that digests flexible glycine-rich fusion protein linkers; GlyCLICK, a conjugation technology;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is GENOVIS AB SE-40's market cap?
GENOVIS AB SE-40's market capitalization is EUR 119.00M.
What does GENOVIS AB SE-40 do?
Genovis AB (publ.) develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia. The company provides FabRICATOR, FabALACTICA, FabRICATOR Z, GingisKHAN, FabULOUS (SpeB), a cysteine protease; FabDELLO, a protease that digests human IgG1; IgASAP, an IgA-digesting enzyme; and IgMBRAZOR, an IgM-specific protease.